Cargando…

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Chen, Yingzhu, Lu, Shuai, Jia, Hao, Deng, Yao, Zhou, Jianfang, Huang, Baoying, Yu, Yueyang, Lan, Jiaming, Wang, Wenling, Lou, Yongliang, Qin, Kun, Tan, Wenjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520321/ https://www.ncbi.nlm.nih.gov/pubmed/28655936 http://dx.doi.org/10.1038/emi.2017.50

Ejemplares similares

A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
por: Chen, Yingzhu, et al.
Publicado: (2017)

Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein
por: Zhou, Haixia, et al.
Publicado: (2019)

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
por: Jiaming, Lan, et al.
Publicado: (2017)

Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus
por: Lan, Jiaming, et al.
Publicado: (2018)

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
por: Deng, Yao, et al.
Publicado: (2018)

Genetic and antigenic characterization of recombinant nucleocapsid proteins derived from canine coronavirus and canine respiratory coronavirus in China
por: Lu, Shuai, et al.
Publicado: (2016)

Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein
por: Widjaja, Ivy, et al.
Publicado: (2019)

Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
por: Suryadevara, Naveenchandra, et al.
Publicado: (2021)

Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China
por: Wang, Wenling, et al.
Publicado: (2016)

Crystal structure of the N-terminal domain of human Timeless and its interaction with Tipin
por: Holzer, Sandro, et al.
Publicado: (2020)

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
por: Yu, Xiaojuan, et al.
Publicado: (2015)

Corrigendum to “Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge” [EBioMedicine 2 (2015) 1438-1446]
por: Lan, Jiaming, et al.
Publicado: (2021)

Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein
por: Goo, Junghyun, et al.
Publicado: (2020)

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
por: Li, Yan, et al.
Publicado: (2015)

Structural Definition of a Unique Neutralization Epitope on the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
por: Zhang, Senyan, et al.
Publicado: (2018)

Syndromic Surveillance System for MERS-CoV as New Early Warning and Identification Approach [Corrigendum]
Publicado: (2020)

Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins
por: Wang, Zijun, et al.
Publicado: (2022)

Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses
por: Wang, Huijuan, et al.
Publicado: (2019)

Corrigendum to “Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus” Journal of Clinical Virology 45 (2009) 54–60
por: Chan, C.M., et al.
Publicado: (2022)

Discovery of a novel canine respiratory coronavirus support genetic recombination among betacoronavirus1
por: Lu, Shuai, et al.
Publicado: (2017)

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015)

Measurement and modeling of intrinsic transcription terminators
por: Cambray, Guillaume, et al.
Publicado: (2016)

Molecular Evolution and Structural Mapping of N-Terminal Domain in Spike Gene of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
por: Naeem, Asif, et al.
Publicado: (2020)

Corrigendum to ’Single domain antibodies derived from ancient animals as broadly neutralizing agents for SARS-CoV-2 and other coronaviruses’: Biomedical Engineering Advances 4 (2022) 100054
por: Lim, H.T., et al.
Publicado: (2023)

Spiking the MERS-coronavirus receptor
por: Bosch, Berend Jan, et al.
Publicado: (2013)

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants
por: Haslwanter, Denise, et al.
Publicado: (2021)

Mer1p is a modular splicing factor whose function depends on the conserved U2 snRNP protein Snu17p
por: Spingola, Marc, et al.
Publicado: (2006)

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
por: Chi, Xiangyang, et al.
Publicado: (2020)

MicroPheno: predicting environments and host phenotypes from 16S rRNA gene sequencing using a k-mer based representation of shallow sub-samples
por: Asgari, Ehsaneddin, et al.
Publicado: (2019)

A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2013)

Corrigendum: The Need for a Unified Protocol for Termination of Amblyopia Treatment
por: Nassar, Mahmoud M., et al.
Publicado: (2019)

Corrigendum to ‘The psychological impact of COVID-19 pandemic on health careworkers in a MERS-CoV endemic country’ [Journal of Infection and Public Health 13 (2020) 877–882]
por: Temsah, Mohamad-Hani, et al.
Publicado: (2020)

Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro
por: Yang, Ren, et al.
Publicado: (2020)

Crystallization and Structural Determination of the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein
por: Zhou, Haixia, et al.
Publicado: (2019)

Corrigendum to: Contribution of histone N‐terminal tails to the structure and stability of nucleosomes
por: Iwasaki, Wakana, et al.
Publicado: (2018)

Precise location of two novel linear epitopes on the receptor-binding domain surface of MERS-CoV spike protein recognized by two different monoclonal antibodies
por: Wang, Pan, et al.
Publicado: (2022)

Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein
por: Zhang, Shuyuan, et al.
Publicado: (2022)

Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2022)

Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4
por: Xia, Shuai, et al.
Publicado: (2019)

Corrigendum to “A Rare Anatomical Variation of the Termination of Right and Left Cephalic Veins”
por: Maalman, Raymond Saa-Eru, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dv44c5a261vjj0sgsd5jfne001